TY  - JOUR
AU  - Zekri, Khaoula
AU  - Barberán, José
AU  - Zamorano León, José Javier
AU  - Durbán, María
AU  - Andrés Castillo, Alcira
AU  - Navarro Cuéllar, Carlos
AU  - López Farre, Antonio José
AU  - López De Andrés, Ana Isabel
AU  - Jiménez García, Rodrigo
AU  - Martínez Martínez, Carlos Hugo
PY  - 2022
DO  - 10.3390/medicina58111649
SN  - 1648-9144
UR  - https://hdl.handle.net/20.500.14352/72299
T2  - Medicina
AB  - Background and Objectives: Aspirin (ASA) is a commonly used antithrombotic drug that has been demonstrated to reduce venous thromboembolism. The aim was to analyze if geriatric COVID-19 patients undergoing a 100 mg/day Aspirin (ASA) treatment prior to...
LA  - eng
M2  - 1649
PB  - MDPI
KW  - Aspirin
KW  - COVID-19
KW  - Elderly population
KW  - Low molecular weight heparin
KW  - Pulmonary thromboembolism
KW  - Mortality
KW  - Hospital stay
TI  - Analysis of Prior Aspirin Treatment on in-Hospital Outcome of Geriatric COVID-19 Infected Patients
TY  - journal article
VL  - 58
ER  -